Vickie L Capps - Net Worth and Insider Trading
Vickie L Capps Net Worth
The estimated net worth of Vickie L Capps is at least $618,547 dollars as of 2024-05-08. Vickie L Capps is the Director of Silverback Therapeutics Inc and owns about 61,576 shares of Silverback Therapeutics Inc (SBTX) stock worth over $361,451. Vickie L Capps is the Director of Amedisys Inc and owns about 1,780 shares of Amedisys Inc (AMED) stock worth over $167,462. Vickie L Capps is also the Director of NuVasive Inc and owns about 2,000 shares of NuVasive Inc (NUVA) stock worth over $79,500. Besides these, Vickie L Capps also holds Connecture Inc (CNXR) , Otonomy Inc (OTIC) . Details can be seen in Vickie L Capps's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vickie L Capps has not made any transactions after 2022-11-28 and currently still holds the listed stock(s).
Transaction Summary of Vickie L Capps
Vickie L Capps Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vickie L Capps owns 8 companies in total, including Otonomy Inc (OTIC) , Amedisys Inc (AMED) , and NuVasive Inc (NUVA) among others .
Click here to see the complete history of Vickie L Capps’s form 4 insider trades.
Insider Ownership Summary of Vickie L Capps
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTIC | Otonomy Inc | 2022-11-28 | director |
| AMED | Amedisys Inc | 2021-06-08 | director |
| NUVA | NuVasive Inc | 2020-11-09 | director |
 | | 2020-01-23 | director |
| | 2018-04-25 | director |
| | 2020-12-08 | director |
| | 2021-06-10 | director |
| | 2020-12-03 | director |
Vickie L Capps Latest Holdings Summary
Vickie L Capps currently owns a total of 5 stocks. Among these stocks, Vickie L Capps owns 61,576 shares of Silverback Therapeutics Inc (SBTX) as of December 8, 2020, with a value of $361,451 and a weighting of 58.44%. Vickie L Capps owns 1,780 shares of Amedisys Inc (AMED) as of February 25, 2020, with a value of $167,462 and a weighting of 27.07%. Vickie L Capps also owns 2,000 shares of NuVasive Inc (NUVA) as of November 9, 2020, with a value of $79,500 and a weighting of 12.85%. The other 2 stocks Connecture Inc (CNXR) , Otonomy Inc (OTIC) have a combined weighting of 1.64% among all his current holdings.
Latest Holdings of Vickie L Capps
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2020-12-08 | 61,576 | 5.87 | 361,451 |
| AMED | Amedisys Inc | 2020-02-25 | 1,780 | 94.08 | 167,462 |
| NUVA | NuVasive Inc | 2020-11-09 | 2,000 | 39.75 | 79,500 |
| CNXR | Connecture Inc | 2016-06-10 | 29,250 | 0.35 | 10,091 |
| OTIC | Otonomy Inc | 2022-11-28 | 5,000 | 0.01 | 43 |
Holding Weightings of Vickie L Capps
Vickie L Capps Form 4 Trading Tracker
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in Silverback Therapeutics Inc (SBTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Silverback Therapeutics Inc is the acquisition of 9,523 shares on December 8, 2020, which cost Vickie L Capps around $199,983.
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in Amedisys Inc (AMED) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Amedisys Inc is the acquisition of 1,000 shares on February 25, 2020, which cost Vickie L Capps around $187,000.
According to the SEC Form 4 filings, Vickie L Capps has made a total of 1 transactions in NuVasive Inc (NUVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NuVasive Inc is the acquisition of 2,000 shares on November 9, 2020, which cost Vickie L Capps around $96,460.
More details on Vickie L Capps's insider transactions can be found in the Insider Trading History of Vickie L Capps table.Insider Trading History of Vickie L Capps
- 1
Vickie L Capps Trading Performance
GuruFocus tracks the stock performance after each of Vickie L Capps's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vickie L Capps is 13.14%. GuruFocus also compares Vickie L Capps's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vickie L Capps within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vickie L Capps's insider trading performs compared to the benchmark.
Performance of Vickie L Capps
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.1 | | | | | |
| Relative Return to S&P 500(%) | 13.63 | | | | | |
Vickie L Capps Ownership Network
Vickie L Capps Owned Company Details
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
Vickie L Capps is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
Over the past 18 months, Vickie L Capps made 1 insider transaction in Otonomy Inc (OTIC) with a net sale of 42,242.
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,242 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,242 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
Vickie L Capps Mailing Address
Above is the net worth, insider trading, and ownership report for Vickie L Capps. You might contact Vickie L Capps via mailing address: 2985 Scott Street, Vista Ca 92083.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
